Trial Title:
A Clinical Study of V940 Plus Pembrolizumab in People With High-Risk Melanoma (V940-001)
NCT ID:
NCT05933577
Condition:
Melanoma
Conditions: Official terms:
Melanoma
Pembrolizumab
Study type:
Interventional
Study phase:
Phase 3
Overall status:
Active, not recruiting
Study design:
Allocation:
Randomized
Intervention model:
Parallel Assignment
Primary purpose:
Treatment
Masking:
Triple (Participant, Investigator, Outcomes Assessor)
Masking description:
Double blind
Intervention:
Intervention type:
Biological
Intervention name:
V940
Description:
IM injection
Arm group label:
V940 + Pembrolizumab
Other name:
mRNA-4157
Other name:
Individualized neoantigen therapy
Intervention type:
Biological
Intervention name:
Pembrolizumab
Description:
IV infusion
Arm group label:
Placebo + Pembrolizumab
Arm group label:
V940 + Pembrolizumab
Other name:
MK-3475
Other name:
Keytruda®
Intervention type:
Other
Intervention name:
Placebo
Description:
IM injection
Arm group label:
Placebo + Pembrolizumab
Other name:
Normal saline
Other name:
Dextrose
Summary:
The purpose of this study is to learn if V940 which is an individualized neoantigen
therapy (INT; formerly, called messenger ribonucleic acid [mRNA]-4157) with pembrolizumab
(MK-3475) is safe and prevents cancer from returning in people with high-risk melanoma.
Researchers want to know if V940 with pembrolizumab is better than receiving
pembrolizumab alone at preventing the cancer from returning.
Criteria for eligibility:
Criteria:
Inclusion Criteria:
The main inclusion criteria include but are not limited to the following:
- Has surgically resected and histologically/pathologically confirmed diagnosis of
Stage IIB or IIC, III, or IV cutaneous melanoma
- Has not received any prior systemic therapy for their melanoma beyond surgical
resection
- No more than 13 weeks have passed between final surgical resection that rendered the
participant disease-free and the first dose of pembrolizumab
- Is disease free at the time of providing documented consent for the study
- Human immunodeficiency virus (HIV)-infected participants must have well controlled
HIV on anti-retroviral therapy (ART)
Exclusion Criteria:
The main exclusion criteria include but are not limited to the following:
- Has ocular or mucosal melanoma
- Has cancer that has spread to other parts of the body and cannot be removed with
surgery
- Has heart failure within the past 6 months
- Has received prior cancer therapy or another cancer vaccine
- Has another known cancer that that has spread to other parts of the body or has
required treatment within the past 3 years
- Has severe reaction to study medications or any of their substance used to prepare a
drug
- Have not recovered from major surgery or have ongoing surgical complications
Gender:
All
Minimum age:
18 Years
Maximum age:
N/A
Healthy volunteers:
No
Locations:
Facility:
Name:
Highlands Oncology Group ( Site 1943)
Address:
City:
Springdale
Zip:
72762
Country:
United States
Facility:
Name:
UCLA Hematology/Oncology - Westwood (Building 100) ( Site 1918)
Address:
City:
Los Angeles
Zip:
90095
Country:
United States
Facility:
Name:
UCSF Medical Center at Mission Bay ( Site 1929)
Address:
City:
San Francisco
Zip:
94158
Country:
United States
Facility:
Name:
Yale-New Haven Hospital-Yale Cancer Center ( Site 1933)
Address:
City:
New Haven
Zip:
06510
Country:
United States
Facility:
Name:
Orlando Health Cancer Institute ( Site 1937)
Address:
City:
Orlando
Zip:
32806
Country:
United States
Facility:
Name:
Moffitt Cancer Center, Richard M. Shulze Family Foundation Outpatient Center ( Site 1945)
Address:
City:
Tampa
Zip:
33612
Country:
United States
Facility:
Name:
Winship Cancer Institute of Emory University ( Site 1940)
Address:
City:
Atlanta
Zip:
30322
Country:
United States
Facility:
Name:
Northwest Georgia Oncology Centers, a Service of Wellstar Cobb Hospital ( Site 1950)
Address:
City:
Marietta
Zip:
30060
Country:
United States
Facility:
Name:
University of Iowa-Holden Comprehensive Cancer Center ( Site 1935)
Address:
City:
Iowa City
Zip:
52242
Country:
United States
Facility:
Name:
Johns Hopkins Hospital-Sidney Kimmel Comprehensive Cancer Center - Melanoma ( Site 1912)
Address:
City:
Baltimore
Zip:
21287
Country:
United States
Facility:
Name:
Massachusetts General Hospital ( Site 1927)
Address:
City:
Boston
Zip:
02114
Country:
United States
Facility:
Name:
Beth Israel Deaconess Medical Center ( Site 1957)
Address:
City:
Boston
Zip:
02215
Country:
United States
Facility:
Name:
Dana-Farber Cancer Institute ( Site 1956)
Address:
City:
Boston
Zip:
02215
Country:
United States
Facility:
Name:
University of Michigan ( Site 1915)
Address:
City:
Ann Arbor
Zip:
48109
Country:
United States
Facility:
Name:
Cancer and Hematology Centers of Western Michigan ( Site 1932)
Address:
City:
Grand Rapids
Zip:
49503
Country:
United States
Facility:
Name:
John Theurer Cancer Center at Hackensack University Medical Center ( Site 1944)
Address:
City:
Hackensack
Zip:
07601
Country:
United States
Facility:
Name:
Atlantic Health System ( Site 1925)
Address:
City:
Morristown
Zip:
07960
Country:
United States
Facility:
Name:
Valley Health Systems - Ridgewood Campus ( Site 1947)
Address:
City:
Ridgewood
Zip:
07450
Country:
United States
Facility:
Name:
Perlmutter Cancer Center at NYU Langone Hospital - Long Island ( Site 1958)
Address:
City:
Mineola
Zip:
11501
Country:
United States
Facility:
Name:
NYU Langone Health-Perlmutter Cancer Center ( Site 1917)
Address:
City:
New York
Zip:
10016
Country:
United States
Facility:
Name:
Columbia University Irving Medical Center-CUIMC Herbert Irving Comprehensive Cancer Center Clinical
Address:
City:
New York
Zip:
10032
Country:
United States
Facility:
Name:
Memorial Sloan Kettering Cancer Center ( Site 1914)
Address:
City:
New York
Zip:
10065
Country:
United States
Facility:
Name:
University of North Carolina Medical Center-Lineberger Comprehensive Cancer Center ( Site 1949)
Address:
City:
Chapel Hill
Zip:
27599
Country:
United States
Facility:
Name:
Duke Cancer Institute ( Site 1911)
Address:
City:
Durham
Zip:
27710
Country:
United States
Facility:
Name:
Hospital of the University of Pennsylvania Perelman Center for Advanced Medicine ( Site 1905)
Address:
City:
Philadelphia
Zip:
19104
Country:
United States
Facility:
Name:
UPMC Hillman Cancer Center ( Site 1909)
Address:
City:
Pittsburgh
Zip:
15232
Country:
United States
Facility:
Name:
Medical University of South Carolina-Hollings Cancer Center ( Site 1934)
Address:
City:
Charleston
Zip:
29425
Country:
United States
Facility:
Name:
Sanford Cancer Center ( Site 1951)
Address:
City:
Sioux Falls
Zip:
57104
Country:
United States
Facility:
Name:
SCRI Oncology Partners ( Site 1910)
Address:
City:
Nashville
Zip:
37203
Country:
United States
Facility:
Name:
Texas Oncology - Austin ( Site 1903)
Address:
City:
Austin
Zip:
78731
Country:
United States
Facility:
Name:
Texas Oncology - Dallas (Sammons) ( Site 1902)
Address:
City:
Dallas
Zip:
75246
Country:
United States
Facility:
Name:
University of Texas MD Anderson Cancer Center ( Site 1920)
Address:
City:
Houston
Zip:
77030
Country:
United States
Facility:
Name:
Inova Schar Cancer Institute ( Site 1900)
Address:
City:
Fairfax
Zip:
22031
Country:
United States
Facility:
Name:
Fred Hutchinson Cancer Center ( Site 1901)
Address:
City:
Seattle
Zip:
98109
Country:
United States
Facility:
Name:
Hospital Italiano de Buenos Aires-Clinical Oncology ( Site 2202)
Address:
City:
Caba
Zip:
C1199ABB
Country:
Argentina
Facility:
Name:
Instituto Alexander Fleming-Alexander Fleming ( Site 2203)
Address:
City:
Ciudad Autónoma de Buenos Aires
Zip:
1426
Country:
Argentina
Facility:
Name:
Centro Privado de RMI Río Cuarto S.A. II ( Site 2201)
Address:
City:
Río Cuarto
Zip:
X5800ALB
Country:
Argentina
Facility:
Name:
Hospital Aleman ( Site 2200)
Address:
City:
Buenos Aires
Zip:
C1118AAT
Country:
Argentina
Facility:
Name:
Sanatorio Finochietto ( Site 2205)
Address:
City:
Buenos Aires
Zip:
C1187AAN
Country:
Argentina
Facility:
Name:
Clinica Adventista Belgrano-Oncology ( Site 2204)
Address:
City:
Caba
Zip:
1430
Country:
Argentina
Facility:
Name:
Westmead Hospital-Department of Medical Oncology ( Site 1001)
Address:
City:
Westmead
Zip:
2145
Country:
Australia
Facility:
Name:
Melanoma Institute Australia-Clinical Trials Unit ( Site 1000)
Address:
City:
Wollstonecraft
Zip:
2065
Country:
Australia
Facility:
Name:
Princess Alexandra Hospital ( Site 1003)
Address:
City:
Brisbane
Zip:
4102
Country:
Australia
Facility:
Name:
Peter MacCallum Cancer Centre-Parkville Cancer Clinical Trials Unit (PCCTU) ( Site 1005)
Address:
City:
Melbourne
Zip:
3000
Country:
Australia
Facility:
Name:
Paula Fox Melanoma & Cancer Centre ( Site 1004)
Address:
City:
Melbourne
Zip:
3004
Country:
Australia
Facility:
Name:
One Clinical Research ( Site 1002)
Address:
City:
Nedlands
Zip:
6009
Country:
Australia
Facility:
Name:
UZ Brussel-Medische oncologie ( Site 3405)
Address:
City:
Brussels
Zip:
1090
Country:
Belgium
Facility:
Name:
Ziekenhuis Oost-Limburg, Campus St.-Jan ( Site 3402)
Address:
City:
Genk
Zip:
3600
Country:
Belgium
Facility:
Name:
UZ Gent ( Site 3403)
Address:
City:
Gent
Zip:
9000
Country:
Belgium
Facility:
Name:
UZ Leuven ( Site 3400)
Address:
City:
Leuven
Zip:
3000
Country:
Belgium
Facility:
Name:
AZ Groeninge Campus Kennedylaan-Oncology ( Site 3401)
Address:
City:
Kortrijk
Zip:
8500
Country:
Belgium
Facility:
Name:
Centro Avançado de Tratamento Oncológico- CENANTRON ( Site 2303)
Address:
City:
Belo Horizonte
Zip:
30130-090
Country:
Brazil
Facility:
Name:
ONCOSITE - Centro de Pesquisa Clinica em Oncologia ( Site 2302)
Address:
City:
Ijui
Zip:
98700-000
Country:
Brazil
Facility:
Name:
Hospital Nossa Senhora da Conceição ( Site 2309)
Address:
City:
Porto Alegre
Zip:
91350-200
Country:
Brazil
Facility:
Name:
Instituto Nacional de Câncer - INCA-Pesquisa Clinica HC II ( Site 2305)
Address:
City:
Rio de Janeiro
Zip:
20220-410
Country:
Brazil
Facility:
Name:
ICESP - INSTITUTO DO CÂNCER DO ESTADO DE SÃO PAULO ( Site 2300)
Address:
City:
Sao Paulo
Zip:
01246-000
Country:
Brazil
Facility:
Name:
Cross Cancer Institute ( Site 1104)
Address:
City:
Edmonton
Zip:
T6G 1Z2
Country:
Canada
Facility:
Name:
BC Cancer Vancouver-Clinical Trials Unit ( Site 1106)
Address:
City:
Vancouver
Zip:
V5Z 4E6
Country:
Canada
Facility:
Name:
William Osler Health System ( Site 1105)
Address:
City:
Brampton
Zip:
L6R 3J7
Country:
Canada
Facility:
Name:
Sunnybrook Research Institute ( Site 1103)
Address:
City:
Toronto
Zip:
M4N 3M5
Country:
Canada
Facility:
Name:
Princess Margaret Cancer Centre-Division of Medical Oncology and Hematology ( Site 1102)
Address:
City:
Toronto
Zip:
M5G 2M9
Country:
Canada
Facility:
Name:
Centre Hospitalier de l'Université de Montréal-Unité de Recherche Clinique en Oncologie et Hématolo
Address:
City:
Montréal
Zip:
H2X 0X9
Country:
Canada
Facility:
Name:
Centre intégré de cancérologie du CHU de Québec Université L-Hemato-Oncology ( Site 1101)
Address:
City:
Quebec City
Zip:
G1J 1Z4
Country:
Canada
Facility:
Name:
FALP-UIDO ( Site 2400)
Address:
City:
Santiago
Zip:
7500921
Country:
Chile
Facility:
Name:
Clínica UC San Carlos de Apoquindo-Hemato-Oncology ( Site 2402)
Address:
City:
Santiago
Zip:
7620002
Country:
Chile
Facility:
Name:
Bradfordhill ( Site 2401)
Address:
City:
Santiago
Zip:
8420383
Country:
Chile
Facility:
Name:
Clinica Somer-Unidad de Investigacion y Docencia ( Site 2506)
Address:
City:
Rionegro
Zip:
054040
Country:
Colombia
Facility:
Name:
Oncomedica S.A.S ( Site 2503)
Address:
City:
Montería
Zip:
230002
Country:
Colombia
Facility:
Name:
Clinica Colsanitas S.A, Sede Clínica Universitaria Colombia-Center Investigator ( Site 2500)
Address:
City:
Bogota
Zip:
111321
Country:
Colombia
Facility:
Name:
Fundación Valle del Lili ( Site 2505)
Address:
City:
Cali
Zip:
760032
Country:
Colombia
Facility:
Name:
Herlev and Gentofte Hospital ( Site 3301)
Address:
City:
Copenhagen
Zip:
2730
Country:
Denmark
Facility:
Name:
Aalborg Universitetshospital, Syd ( Site 3302)
Address:
City:
Aalborg
Zip:
9000
Country:
Denmark
Facility:
Name:
Odense Universitetshospital ( Site 3300)
Address:
City:
Odense C
Zip:
5000
Country:
Denmark
Facility:
Name:
Centre Hospitalier Universitaire de Nice - Hôpital l'Archet-Dermatology Department ( Site 1211)
Address:
City:
Nice cedex 3
Zip:
06200
Country:
France
Facility:
Name:
Assistance Publique Hôpitaux de Marseille - Hôpital de la Ti-Service de Dermatologie et Cancérologi
Address:
City:
Marseille
Zip:
13385
Country:
France
Facility:
Name:
Centre Georges François Leclerc ( Site 1210)
Address:
City:
Dijon
Zip:
21079
Country:
France
Facility:
Name:
CHU Besançon ( Site 1209)
Address:
City:
Besançon
Zip:
25030
Country:
France
Facility:
Name:
CHU de Bordeaux Hop St ANDRE-Service de Dermatologie ( Site 1204)
Address:
City:
Bordeaux
Zip:
33075
Country:
France
Facility:
Name:
Centre Eugène Marquis Rennes - Centre de Lutte Contre le Cancer ( Site 1206)
Address:
City:
Rennes
Zip:
35042
Country:
France
Facility:
Name:
Hopital Claude Huriez - CHU de Lille ( Site 1207)
Address:
City:
Lille
Zip:
59037
Country:
France
Facility:
Name:
centre hospitalier lyon sud-Service de dermatologie ( Site 1202)
Address:
City:
Pierre-Bénite
Zip:
69310
Country:
France
Facility:
Name:
CHU d'Amiens-Picardie - Hôpital Sud-Dermatologie ( Site 1208)
Address:
City:
Amiens
Zip:
80054
Country:
France
Facility:
Name:
Gustave Roussy-Dermatologie ( Site 1201)
Address:
City:
Villejuif
Zip:
94800
Country:
France
Facility:
Name:
Hôpital Saint-Louis ( Site 1200)
Address:
City:
Paris
Zip:
75010
Country:
France
Facility:
Name:
Universitätsmedizin Mannheim ( Site 1305)
Address:
City:
Mannheim
Zip:
68167
Country:
Germany
Facility:
Name:
Universitaetsklinikum Augsburg ( Site 1312)
Address:
City:
Augsburg
Zip:
86156
Country:
Germany
Facility:
Name:
Klinik und Poliklinik für Dermatologie und Allergologie-Dermato-oncology ( Site 1315)
Address:
City:
München
Zip:
80337
Country:
Germany
Facility:
Name:
Universitätsmedizin Rostock-Klinik und Poliklinik für Dermatologie und Venerologie ( Site 1310)
Address:
City:
Rostock
Zip:
18057
Country:
Germany
Facility:
Name:
Universitätsmedizin Göttingen - Georg-August-Universität-Dermatology ( Site 1308)
Address:
City:
Göttingen
Zip:
37075
Country:
Germany
Facility:
Name:
Universitaetsklinikum Essen-Klinik für Dermatologie, Venerologie und Allergologie ( Site 1300)
Address:
City:
Essen
Zip:
45147
Country:
Germany
Facility:
Name:
Universitaetsklinikum Koeln ( Site 1307)
Address:
City:
Köln
Zip:
50937
Country:
Germany
Facility:
Name:
Johannes Wesling Klinikum Minden-Skin Cancer Center Minden ( Site 1301)
Address:
City:
Minden
Zip:
32429
Country:
Germany
Facility:
Name:
Universitaetsklinikum des Saarlandes ( Site 1313)
Address:
City:
Homburg
Zip:
66424
Country:
Germany
Facility:
Name:
SRH Wald-Klinikum Gera-Zentrum für klinische Studien ( Site 1306)
Address:
City:
Gera
Zip:
07548
Country:
Germany
Facility:
Name:
Charité Universitaetsmedizin Berlin - Campus Mitte-Hauttumorcentrum Charité (HTCC) ( Site 1302)
Address:
City:
Berlin
Zip:
10115
Country:
Germany
Facility:
Name:
Universitaetsklinikum Hamburg-Eppendorf ( Site 1309)
Address:
City:
Hamburg
Zip:
20246
Country:
Germany
Facility:
Name:
General Hospital of Athens "Laiko"-First Department of Internal Medicine ( Site 3700)
Address:
City:
Athens
Zip:
115 26
Country:
Greece
Facility:
Name:
Metropolitan Hospital-A' Oncology Dpt ( Site 3701)
Address:
City:
Neo Faliro
Zip:
185 47
Country:
Greece
Facility:
Name:
Bioclinic Thessalonikis Private Clinic Single Member S.A.-Oncology ( Site 3703)
Address:
City:
Thessaloniki
Zip:
546 22
Country:
Greece
Facility:
Name:
European Interbalkan Medical Center-Oncology Department ( Site 3702)
Address:
City:
Thessaloniki
Zip:
57001
Country:
Greece
Facility:
Name:
Emek Medical Center ( Site 2003)
Address:
City:
Afula
Zip:
1834111
Country:
Israel
Facility:
Name:
Hadassah Medical Center ( Site 2004)
Address:
City:
Jerusalem
Zip:
9112001
Country:
Israel
Facility:
Name:
Rabin Medical Center ( Site 2000)
Address:
City:
Petah Tikva
Zip:
4941492
Country:
Israel
Facility:
Name:
Sheba Medical Center ( Site 2001)
Address:
City:
Ramat Gan
Zip:
5265601
Country:
Israel
Facility:
Name:
Istituto Europeo di Oncologia IRCCS ( Site 1404)
Address:
City:
Milano
Zip:
20141
Country:
Italy
Facility:
Name:
Fondazione IRCCS Istituto Nazionale dei Tumori ( Site 1401)
Address:
City:
Milan
Zip:
20133
Country:
Italy
Facility:
Name:
Azienda Ospedaliero Universitaria Senese-U.O.C. Immunoterapia Oncologica ( Site 1402)
Address:
City:
Siena
Zip:
53100
Country:
Italy
Facility:
Name:
AO Santa Maria della Misericordia ( Site 1403)
Address:
City:
Perugia
Zip:
06129
Country:
Italy
Facility:
Name:
Istituto Nazionale Tumori IRCCS Fondazione Pascale-s.c. melanoma, immunoterapia oncologica e terapi
Address:
City:
Napoli
Zip:
80131
Country:
Italy
Facility:
Name:
Nagoya University Hospital ( Site 4201)
Address:
City:
Nagoya
Zip:
466-8560
Country:
Japan
Facility:
Name:
Shizuoka Cancer Center ( Site 4202)
Address:
City:
Nagaizumi-cho,Sunto-gun
Zip:
411-8777
Country:
Japan
Facility:
Name:
National Cancer Center Hospital ( Site 4200)
Address:
City:
Chuo
Zip:
104-0045
Country:
Japan
Facility:
Name:
Kyungpook National University Chilgok Hospital-Hematology/oncology ( Site 3904)
Address:
City:
Daegu
Zip:
41404
Country:
Korea, Republic of
Facility:
Name:
Chungnam national university hospital-Department of Internal Medicine ( Site 3903)
Address:
City:
Daejeon
Zip:
35015
Country:
Korea, Republic of
Facility:
Name:
Seoul National University Hospital-Oncology ( Site 3902)
Address:
City:
Seoul
Zip:
03080
Country:
Korea, Republic of
Facility:
Name:
Severance Hospital, Yonsei University Health System-Medical oncology ( Site 3901)
Address:
City:
Seoul
Zip:
03722
Country:
Korea, Republic of
Facility:
Name:
Samsung Medical Center-Division of Hematology/Oncology ( Site 3900)
Address:
City:
Seoul
Zip:
06351
Country:
Korea, Republic of
Facility:
Name:
Capital, Coast and Hutt Valley District - Wellington Regional Hospital ( Site 1502)
Address:
City:
Newtown
Zip:
6021
Country:
New Zealand
Facility:
Name:
Harbour Cancer & Wellness ( Site 1500)
Address:
City:
Auckland
Zip:
1023
Country:
New Zealand
Facility:
Name:
Centrum Onkologii im. Prof. Franciszka Lukaszczyka-Ambulatorium Chemioterapii ( Site 2908)
Address:
City:
Bydgoszcz
Zip:
85-796
Country:
Poland
Facility:
Name:
Mazowiecki Szpital Wojewódzki w Siedlcach-Siedleckie Centrum Onkologii ( Site 2903)
Address:
City:
Siedlce
Zip:
08-110
Country:
Poland
Facility:
Name:
Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie - Panstwowy Instytut Badawczy w Warszawie (
Address:
City:
Warszawa
Zip:
02-781
Country:
Poland
Facility:
Name:
Bialostockie Centrum Onkologii ( Site 2905)
Address:
City:
Bialystok
Zip:
15-027
Country:
Poland
Facility:
Name:
Uniwersyteckie Centrum Kliniczne-Klinika Chirurgii Onkologicznej, Transplantacyjnej i Ogólnej ( Site
Address:
City:
Gdańsk
Zip:
80-214
Country:
Poland
Facility:
Name:
Narodowy Instytut Onkologii - Oddzial w Gliwicach ( Site 2907)
Address:
City:
Gliwice
Zip:
44-101
Country:
Poland
Facility:
Name:
Swietokrzyskie Centrum Onkologii, Samodzielny Publiczny Zakl-Klinika Onkologii Klinicznej, Dzial Ch
Address:
City:
Kielce
Zip:
25-734
Country:
Poland
Facility:
Name:
Uniwersytecki Szpital Kliniczny w Poznaniu ( Site 2909)
Address:
City:
Poznan
Zip:
60-569
Country:
Poland
Facility:
Name:
Zachodniopomorskie Centrum Onkologii ( Site 2904)
Address:
City:
Szczecin
Zip:
71-730
Country:
Poland
Facility:
Name:
Instituto Português de Oncologia de Lisboa Francisco Gentil ( Site 3601)
Address:
City:
Lisbon
Zip:
1099-023
Country:
Portugal
Facility:
Name:
Unidade Local de Saude de Santa Maria - Hospital de Santa Maria ( Site 3603)
Address:
City:
Lisbon
Zip:
1649-035
Country:
Portugal
Facility:
Name:
Unidade Local de Saude Lisboa Ocidental - Hospital de São Francisco Xavier ( Site 3602)
Address:
City:
Lisboa
Zip:
1449-005
Country:
Portugal
Facility:
Name:
Instituto Português de Oncologia do Porto Francisco Gentil, EPE ( Site 3604)
Address:
City:
Porto
Zip:
4200-072
Country:
Portugal
Facility:
Name:
Medical Oncology Centre of Rosebank ( Site 4106)
Address:
City:
Johannesburg
Zip:
2196
Country:
South Africa
Facility:
Name:
Wilgers Oncology Centre ( Site 4103)
Address:
City:
Pretoria
Zip:
0040
Country:
South Africa
Facility:
Name:
Cape Town Oncology Trials ( Site 4100)
Address:
City:
Cape Town
Zip:
7570
Country:
South Africa
Facility:
Name:
HOSPITAL CLÍNIC DE BARCELONA-ICHMO- Clinic Institut of Haematological and Oncological diseases ( Sit
Address:
City:
Barcelona
Zip:
08036
Country:
Spain
Facility:
Name:
Hospital Universitario Ramón y Cajal ( Site 1602)
Address:
City:
Madrid
Zip:
28034
Country:
Spain
Facility:
Name:
HOSPITAL UNIVERSITARIO QUIRONSALUD MADRID ( Site 1603)
Address:
City:
Pozuelo de Alarcon
Zip:
28223
Country:
Spain
Facility:
Name:
H.R.U Málaga - Hospital General-Oncology ( Site 1605)
Address:
City:
Málaga
Zip:
29011
Country:
Spain
Facility:
Name:
HOSPITAL CLINICO DE VALENCIA ( Site 1604)
Address:
City:
Valencia
Zip:
46010
Country:
Spain
Facility:
Name:
Hospital Universitari Vall d'Hebron-Departamento de Oncologia- VHIO ( Site 1601)
Address:
City:
Barcelona
Zip:
08035
Country:
Spain
Facility:
Name:
Skånes Universitetssjukhus Lund ( Site 3201)
Address:
City:
Lund
Zip:
22185
Country:
Sweden
Facility:
Name:
Sahlgrenska Universitetssjukhuset ( Site 3200)
Address:
City:
Gothenburg
Zip:
413 45
Country:
Sweden
Facility:
Name:
Kantonsspital Graubünden-Medizin ( Site 1703)
Address:
City:
Chur
Zip:
7000
Country:
Switzerland
Facility:
Name:
UniversitätsSpital Zürich-Dermatology ( Site 1700)
Address:
City:
Zürich Flughafen
Zip:
8058
Country:
Switzerland
Facility:
Name:
Chang Gung Memorial Hospital at Kaohsiung (Site 4000)
Address:
City:
Kaohsiung
Zip:
83301
Country:
Taiwan
Facility:
Name:
National Cheng Kung University Hospital-Clinical Trial Center ( Site 4004)
Address:
City:
Tainan
Zip:
704
Country:
Taiwan
Facility:
Name:
National Taiwan University Hospital (Site 4001)
Address:
City:
Taipei
Zip:
10002
Country:
Taiwan
Facility:
Name:
Chang Gung Medical Foundation-Linkou Branch ( Site 4003)
Address:
City:
Taoyuan
Zip:
33305
Country:
Taiwan
Facility:
Name:
Hacettepe Universite Hastaneleri ( Site 3006)
Address:
City:
Ankara
Zip:
06230
Country:
Turkey
Facility:
Name:
Memorial Ankara Hastanesi-Medical Oncology ( Site 3010)
Address:
City:
Ankara
Zip:
06520
Country:
Turkey
Facility:
Name:
Ankara Bilkent Şehir Hastanesi-Medical Oncology ( Site 3002)
Address:
City:
Ankara
Zip:
06800
Country:
Turkey
Facility:
Name:
Acibadem Universitesi Atakent Hastanesi-Medical Oncology ( Site 3008)
Address:
City:
Istanbul
Zip:
34303
Country:
Turkey
Facility:
Name:
TC Saglik Bakanligi Goztepe Prof. Dr. Suleyman Yalcin Sehir Hastanesi-oncology ( Site 3003)
Address:
City:
Istanbul
Zip:
34722
Country:
Turkey
Facility:
Name:
Ege University Medical Faculty Hospital ( Site 3011)
Address:
City:
Izmir
Zip:
35100
Country:
Turkey
Facility:
Name:
I.E.U. Medical Point Hastanesi-Oncology ( Site 3005)
Address:
City:
Izmir
Zip:
35575
Country:
Turkey
Facility:
Name:
Bristol Haematology and Oncology Centre ( Site 1811)
Address:
City:
Bristol
Zip:
BS2 8ED
Country:
United Kingdom
Facility:
Name:
Addenbrooke's Hospital ( Site 1800)
Address:
City:
Cambridge
Zip:
CB2 2QQ
Country:
United Kingdom
Facility:
Name:
Norfolk and Norwich University Hospitals NHS Foundation Trust ( Site 1813)
Address:
City:
Cringleford
Zip:
NR4 7UY
Country:
United Kingdom
Facility:
Name:
ROYAL MARSDEN HOSPITAL (CHELSEA) ( Site 1804)
Address:
City:
London
Zip:
SW3 6JJ
Country:
United Kingdom
Facility:
Name:
University College London Hospital ( Site 1807)
Address:
City:
London
Zip:
NW1 2PG
Country:
United Kingdom
Facility:
Name:
Western General Hospital ( Site 1806)
Address:
City:
Edinburgh
Zip:
EH4 2XU
Country:
United Kingdom
Facility:
Name:
The Churchill Hospital ( Site 1805)
Address:
City:
Oxford
Zip:
OX3 7LE
Country:
United Kingdom
Facility:
Name:
St James's University Hospital-Leeds Cancer Centre ( Site 1808)
Address:
City:
Leeds
Zip:
LS9 7TF
Country:
United Kingdom
Facility:
Name:
The Christie NHS Foundation Trust ( Site 1814)
Address:
City:
Manchester
Zip:
m20 4bx
Country:
United Kingdom
Start date:
July 19, 2023
Completion date:
September 26, 2030
Lead sponsor:
Agency:
Merck Sharp & Dohme LLC
Agency class:
Industry
Collaborator:
Agency:
ModernaTX, Inc.
Agency class:
Industry
Source:
Merck Sharp & Dohme LLC
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT05933577
http://www.merckclinicaltrials.com
https://trialstransparency.merckclinicaltrials.com/Study.aspx?id=V940-001&&kw=V940-001